SPONSOR
Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics
Total Trials
2
Recruiting
2
Phases
Phase 3
Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics is a clinical research sponsor with 2 registered studies on ClinicalTrials.gov, of which 2 are actively recruiting participants. Research covers conditions including Obesity, Overweight, Chronic Weight Management, Type2 Diabetes Mellitus.
The trial portfolio spans Phase 3 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics
How many clinical trials has Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics sponsored?
ClinicalMetric currently tracks 2 clinical trials sponsored by Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics, of which 2 are actively recruiting participants. These trials cover conditions including Obesity, Overweight, Chronic Weight Management. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics research focus on?
Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics clinical trials span Obesity, Overweight, Chronic Weight Management, Type2 Diabetes Mellitus. The research pipeline includes Phase 3 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics clinical trial?
To participate in a Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics trials with current recruitment status updated daily.
Clinical Trials by Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics
NCT07654361 Phase 3
Recruiting
Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)
Obesity
NCT07654374 Phase 3
Recruiting
A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
Obesity
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology